Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors von Wilson, Timothy R., Fridlyand, Jane, Yan, Yibing, Penuel, Elicia, Burton, Luciana, Chan, Emily, Peng, Jing, Lin, Eva, Wang, Yulei, Sosman, Jeff, Ribas, Antoni, Li, Jiang, Moffat, John, Sutherlin, Daniel P., Koeppen, Hartmut, Merchant, Mark, Neve, Richard, Settleman, Jeff

Volltext

MEK + CDK4 a regimen for non-BRAF V6000 melanoma von Sosman, Jeff

Volltext

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma von KIRKWOOD, John M, BASTHOLT, Lars, DUMMER, Reinhard, ROBERT, Caroline, SOSMAN, Jeff, LARKIN, James, HERSEY, Peter, MIDDLETON, Mark, CANTARINI, Mireille, ZAZULINA, Victoria, KEMSLEY, Karin

Volltext

A phase I study of continuous oral dosing of OSI-906, a dual inhibitor of insulin-like growth factor-1 and insulin receptors, in patients with advanced solid tumors von Puzanov, Igor, Lindsay, Colin R, Goff, Laura, Sosman, Jeff, Gilbert, Jill, Berlin, Jordan, Poondru, Srinivasu, Simantov, Ronit, Gedrich, Rich, Stephens, Andrew, Chan, Emily, Evans, T R Jeffry

Volltext

Aberrant DNA methylation in malignant melanoma von Schinke, Carolina, Mo, Yongkai, Yu, Yiting, Amiri, Kathy, Sosman, Jeff, Greally, John, Verma, Amit

Volltext

Clinical and immunological effects of recombinant interleukin 2 given by repetitive weekly cycles to patients with cancer von SONDEL, P. M, KOHLER, P. C, HANK, J. A, MOORE, K. H, ROSENTHAL, N. S, SOSMAN, J. A, BECHHOFER, R, STORER, B

Volltext

Abstract PR6: Widespread potential for growth factor-driven resistance to anti-cancer kinase inhibitors von Wilson, Timothy R., Fridlyand, Jane, Ribas, Antoni, Li, Jiang, Koeppen, Hartmut, Merchant, Mark, Neve, Richard, Settleman, Jeff, Yan, Yibing, Penuel, Elicia, Burton, Luciana, Chan, Emily, Peng, Jing, Lin, Eva, Wang, Yulei, Sosman, Jeff

Volltext

Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012" von Ascierto, Paolo A, Grimaldi, Antonio M, Acquavella, Nicolas, Borgognoni, Lorenzo, Calabrò, Luana, Cascinelli, Natale, Cesano, Alessandra, Del Vecchio, Michele, Eggermont, Alexander M, Faries, Mark, Ferrone, Soldano, Fox, Bernard A, Gajewski, Thomas F, Galon, Jérôme, Gnjatic, Sacha, Gogas, Helen, Kashani-Sabet, Mohammed, Kaufman, Howard L, Larkin, James, Lo, Roger S, Mantovani, Alberto, Margolin, Kim, Melief, Cornelis, McArthur, Grant, Palmieri, Giuseppe, Puzanov, Igor, Ribas, Antoni, Seliger, Barbara, Sosman, Jeff, Suenaert, Peter, Tarhini, Ahmad A, Trinchieri, Giorgio, Vidal-Vanaclocha, Fernando, Wang, Ena, Ciliberto, Gennaro, Mozzillo, Nicola, Marincola, Francesco M, Thurin, Magdalena

Volltext

New Options and New Questions: How to Select and Sequence Therapies for Patients with Metastatic Melanoma von Flaherty, Keith T., Sosman, Jeff A., Atkins, Michael B.

Volltext

New options and new questions: how to select and sequence therapies for patients with metastatic melanoma von Flaherty, Keith T, Sosman, Jeff A, Atkins, Michael B

Volltext

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012” von Ascierto, Paolo A, Grimaldi, Antonio M, Acquavella, Nicolas, Borgognoni, Lorenzo, Calabrò, Luana, Cascinelli, Natale, Cesano, Alessandra, Del Vecchio, Michele, Eggermont, Alexander M, Faries, Mark, Ferrone, Soldano, Fox, Bernard A, Gajewski, Thomas F, Galon, Jérôme, Gnjatic, Sacha, Gogas, Helen, Kashani-Sabet, Mohammed, Kaufman, Howard L, Larkin, James, Lo, Roger S, Mantovani, Alberto, Margolin, Kim, Melief, Cornelis, McArthur, Grant, Palmieri, Giuseppe, Puzanov, Igor, Ribas, Antoni, Seliger, Barbara, Sosman, Jeff, Suenaert, Peter, Tarhini, Ahmad A, Trinchieri, Giorgio, Vidal-Vanaclocha, Fernando, Wang, Ena, Ciliberto, Gennaro, Mozzillo, Nicola, Marincola, Francesco M, Thurin, Magdalena

Volltext

Kidney cancer: the Cytokine Working Group experience (1986-2001): part II. Management of IL-2 toxicity and studies with other cytokines von Dutcher, J, Atkins, M B, Margolin, K, Weiss, G, Clark, J, Sosman, J, Logan, T, Aronson, F, Mier, J

Volltext

Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicity von SOSMAN, J. A, KOHLER, P. C, HANK, J, MOORE, K. H, BECHHOFER, R, STORER, B, SONDEL, P. M

Volltext

Repetitive Weekly Cycles of Interleukin-2. II. Clinical and Immunologic Effects of Dose, Schedule, and Addition of Indomethacin von Sosman, Jeff A., Kohler, Peter C., Hank, Jacquelyn A., Moore, Karen H., Bechhofer, Robin, Storer, Barry, Sonde, Paul M.

Volltext

Kidney cancer: the Cytokine Working Group experience (1986-2001): part I. IL-2-based clinical trials von Atkins, M B, Dutcher, J, Weiss, G, Margolin, K, Clark, J, Sosman, J, Logan, T, Aronson, F, Mier, J

Volltext

A Phase II Trial of High-Dose Mitoxantrone, Carboplatin, and Cyclophosphamide with Autologous Bone Marrow Rescue for Recurrent Epithelial Ovarian Carcinoma: Analysis of Risk Factor... von Stiff, Patrick, Bayer, Robert, Camarda, Maria, Tan, Sally, Dolan, James, Potkul, Ronald, Loutfi, Saoud, Kinch, Laura, Sosman, Jeff, Peace, David, Rad, Nancy, McKenzie, R.Scott

Volltext

High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical... von STIFF, P. J, BAYER, R, TAN, S, CAMARDA, M, SOSMAN, J, PEACE, D, KINCH, L, RAD, N, SAOUD LOUTFI

Volltext

Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation von VOSS, S. D, HANK, J. A, NOBIS, C. A, FISCH, P, SOSMAN, J. A, SONDEL, P. M

Volltext

Phase II study of autologous transplantation with interleukin-2-incubated peripheral blood stem cells and posttransplantation interleukin-2 in relapsed or refractory non-Hodgkin ly... von Van Besien, Koen, Mehra, Rakesh, Wadehra, Navin, Stock, Wendy, Khouri, Issa, Giralt, Sergio, Devine, Steve, Wickrema, Amittha, Peace, David, Sosman, Jeff, Gajewski, Jim, Champlin, Richard

Volltext

The cellular immunotherapy of cancer: Current and potential uses of interleukin-2 von Sondel, Paul M., Hank, Jacquelyn A., Kohler, Peter C., Sosman, Jeff A., Weil-Hillman, Gilda, Fisch, Paul, Bach, Fritz H.

Volltext